Advertisement

Topics

Celtic Pharma in new business strategy

03:48 EDT 13 Sep 2011 |

Published with kind permission of MEDNOUS. Celtic Pharma Holdings, a global private equity group, has launched a new company that will manufacture, register and commercialise products from the companies in its investment portfolio. Called Pro Bono Bio, the new company is a wholly-owned subsidiary of Celtic Pharma Holdings 2, one of Celtic Pharma’s three investment [...]

Original Article: Celtic Pharma in new business strategy

NEXT ARTICLE

More From BioPortfolio on "Celtic Pharma in new business strategy"

Advertisement
Quick Search
Advertisement
Advertisement